370 related articles for article (PubMed ID: 34687392)
21. Multiplatform profiling of meningioma provides molecular insight and prioritization of drug targets for rational clinical trial design.
Everson RG; Hashimoto Y; Freeman JL; Hodges TR; Huse J; Zhou S; Xiu J; Spetzler D; Sanai N; Kim L; Kesari S; Brenner A; De Monte F; Heimberger A; Raza SM
J Neurooncol; 2018 Sep; 139(2):469-478. PubMed ID: 29846894
[TBL] [Abstract][Full Text] [Related]
22. Extracellular vesicles as source for the identification of minimally invasive molecular signatures in glioblastoma.
Rackles E; Lopez PH; Falcon-Perez JM
Semin Cancer Biol; 2022 Dec; 87():148-159. PubMed ID: 36375777
[TBL] [Abstract][Full Text] [Related]
23. Exosomes as a Multicomponent Biomarker Platform in Cancer.
LeBleu VS; Kalluri R
Trends Cancer; 2020 Sep; 6(9):767-774. PubMed ID: 32307267
[TBL] [Abstract][Full Text] [Related]
24. Exosomes as a new frontier of cancer liquid biopsy.
Yu D; Li Y; Wang M; Gu J; Xu W; Cai H; Fang X; Zhang X
Mol Cancer; 2022 Feb; 21(1):56. PubMed ID: 35180868
[TBL] [Abstract][Full Text] [Related]
25. Extracellular vesicles: Toward a clinical application in urological cancer treatment.
Urabe F; Kosaka N; Kimura T; Egawa S; Ochiya T
Int J Urol; 2018 Jun; 25(6):533-543. PubMed ID: 29726046
[TBL] [Abstract][Full Text] [Related]
26. Extracellular Vesicles in Cancer Detection: Hopes and Hypes.
Hu T; Wolfram J; Srivastava S
Trends Cancer; 2021 Feb; 7(2):122-133. PubMed ID: 33008796
[TBL] [Abstract][Full Text] [Related]
27. A Comprehensive Proteomic SWATH-MS Workflow for Profiling Blood Extracellular Vesicles: A New Avenue for Glioma Tumour Surveillance.
Hallal S; Azimi A; Wei H; Ho N; Lee MYT; Sim HW; Sy J; Shivalingam B; Buckland ME; Alexander-Kaufman KL
Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32635403
[TBL] [Abstract][Full Text] [Related]
28. Exosomal tetraspanins as regulators of cancer progression and metastasis and novel diagnostic markers.
Malla RR; Pandrangi S; Kumari S; Gavara MM; Badana AK
Asia Pac J Clin Oncol; 2018 Dec; 14(6):383-391. PubMed ID: 29575602
[TBL] [Abstract][Full Text] [Related]
29. Exosomal biomarkers for cancer diagnosis and patient monitoring.
Makler A; Asghar W
Expert Rev Mol Diagn; 2020 Apr; 20(4):387-400. PubMed ID: 32067543
[No Abstract] [Full Text] [Related]
30. Extracellular vesicles and encapusulated miRNAs as emerging cancer biomarkers for novel liquid biopsy.
Yoshioka Y; Katsuda T; Ochiya T
Jpn J Clin Oncol; 2018 Oct; 48(10):869-876. PubMed ID: 30169666
[TBL] [Abstract][Full Text] [Related]
31. Extracellular Vesicles: Recent Developments in Technology and Perspectives for Cancer Liquid Biopsy.
Nazarenko I
Recent Results Cancer Res; 2020; 215():319-344. PubMed ID: 31605237
[TBL] [Abstract][Full Text] [Related]
32. Exosomes: Diagnostic Biomarkers and Therapeutic Delivery Vehicles for Cancer.
Jiang L; Gu Y; Du Y; Liu J
Mol Pharm; 2019 Aug; 16(8):3333-3349. PubMed ID: 31241965
[TBL] [Abstract][Full Text] [Related]
33. Total DNA methylation as a biomarker of DNA damage and tumor malignancy in intracranial meningiomas.
Barciszewska AM
BMC Cancer; 2020 Jun; 20(1):509. PubMed ID: 32493231
[TBL] [Abstract][Full Text] [Related]
34. Power and promise of exosomes as clinical biomarkers and therapeutic vectors for liquid biopsy and cancer control.
Ma YS; Yang XL; Xin R; Liu JB; Fu D
Biochim Biophys Acta Rev Cancer; 2021 Jan; 1875(1):188497. PubMed ID: 33370570
[TBL] [Abstract][Full Text] [Related]
35. Immunocytochemical analysis of glucose transporter protein-1 (GLUT-1) in typical, brain invasive, atypical and anaplastic meningioma.
van de Nes JA; Griewank KG; Schmid KW; Grabellus F
Neuropathology; 2015 Feb; 35(1):24-36. PubMed ID: 25168354
[TBL] [Abstract][Full Text] [Related]
36. Exploring the role of epidermal growth factor receptor variant III in meningeal tumors.
Rana R; Rathi V; Chauhan K; Jain K; Chhabra SS; Acharya R; Kalra SK; Gupta A; Jain S; Ganguly NK; Yadav DK
PLoS One; 2021; 16(9):e0255133. PubMed ID: 34582442
[TBL] [Abstract][Full Text] [Related]
37. Clinical relevance of extracellular vesicles in hematological neoplasms: from liquid biopsy to cell biopsy.
Trino S; Lamorte D; Caivano A; De Luca L; Sgambato A; Laurenzana I
Leukemia; 2021 Mar; 35(3):661-678. PubMed ID: 33299143
[TBL] [Abstract][Full Text] [Related]
38. Refining Cancer Management Using Integrated Liquid Biopsy.
Qiu J; Xu J; Zhang K; Gu W; Nie L; Wang G; Luo Y
Theranostics; 2020; 10(5):2374-2384. PubMed ID: 32089746
[TBL] [Abstract][Full Text] [Related]
39. Current Advances and Future Perspectives of Cerebrospinal Fluid Biopsy in Midline Brain Malignancies.
Pan Y; Long W; Liu Q
Curr Treat Options Oncol; 2019 Nov; 20(12):88. PubMed ID: 31784837
[TBL] [Abstract][Full Text] [Related]
40. Targeted proteomics in urinary extracellular vesicles identifies biomarkers for diagnosis and prognosis of prostate cancer.
Sequeiros T; Rigau M; Chiva C; Montes M; Garcia-Grau I; Garcia M; Diaz S; Celma A; Bijnsdorp I; Campos A; Di Mauro P; Borrós S; Reventós J; Doll A; Paciucci R; Pegtel M; de Torres I; Sabidó E; Morote J; Olivan M
Oncotarget; 2017 Jan; 8(3):4960-4976. PubMed ID: 27903962
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
